The bill S. 694 proposes an amendment to the Social Security Act, specifically targeting the manufacturer discount program for plasma-derived products. It introduces a phased approach for these products, adjusting the "discounted price" of such medicines over several years...
Simple Explanation
This bill wants to change how we buy special medicines made from blood, by slowly changing their prices over a few years so it's not too fast or sudden.